|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.930 USD | +2.08% |
|
-5.76% | -86.38% |
| Market Cap | 228M 197M 185M 168M 317M 21.71B 322M 2.17B 848M 10.87B 855M 836M 36.25B | P/E 2026 * |
-2.78x | P/E 2027 * | -2.82x |
|---|---|---|---|---|---|
| Enterprise Value | 228M 197M 185M 168M 317M 21.71B 322M 2.17B 848M 10.87B 855M 836M 36.25B | EV / Sales 2026 * |
3.51x | EV / Sales 2027 * | 4.7x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | +2.08% | ||
| 1 week | -5.76% | ||
| Current month | +2.08% | ||
| 1 month | -81.73% | ||
| 3 months | -87.68% | ||
| 6 months | -83.76% | ||
| Current year | -86.38% |
| 1 week | 3.73 | 4.7 | |
| 1 month | 2.96 | 21.53 | |
| Current year | 2.96 | 36.82 | |
| 1 year | 2.96 | 40.37 | |
| 3 years | 2.68 | 40.37 | |
| 5 years | 2.56 | 40.37 | |
| 10 years | 0.88 | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/4/26 | Fiscal year | Director | 22,587 | 0.0393% | ||
| 5/1/26 | Free | Director | 15,500 | 0.0285% | ||
| 5/1/26 | Free | Chief Financial Officer | 52,500 | 0.0965% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.08% | -5.76% | -49.71% | -34.93% | 223M | ||
| -0.70% | +13.34% | +75.61% | +103.83% | 70.85B | ||
| -2.35% | +2.88% | +35.39% | +64.72% | 55.41B | ||
| -1.62% | +34.25% | +17.43% | +491.04% | 29.43B | ||
| -1.35% | +11.52% | +53.25% | +6.46% | 24.12B | ||
| 0.00% | +1.59% | -15.06% | -13.21% | 23.31B | ||
| +0.05% | +6.12% | +46.81% | -21.81% | 18.37B | ||
| +9.77% | +20.16% | +260.17% | +472.38% | 16.99B | ||
| -0.09% | +6.85% | +30.20% | +619.86% | 16.1B | ||
| -3.08% | -8.34% | +37.21% | +138.52% | 13.12B | ||
| Average | +0.21% | +353.07% | +49.13% | +182.69% | 26.79B | |
| Weighted average by Cap. | -0.54% | +350.47% | +56.02% | +166.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 64.76M 56.12M 52.54M 47.94M 90.21M 6.18B 91.72M 616M 241M 3.09B 243M 238M 10.31B | 48.38M 41.92M 39.25M 35.81M 67.39M 4.61B 68.52M 460M 180M 2.31B 182M 178M 7.7B |
| Net income | -82.36M -71.38M -66.82M -60.97M -115M -7.86B -117M -784M -307M -3.93B -309M -303M -13.12B | -83.73M -72.56M -67.93M -61.98M -117M -7.99B -119M -796M -312M -4B -314M -308M -13.34B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | USD 3.930 | +2.08% | 3,325,986 |
| 10/08/26 | USD 3.850 | -5.87% | 3,088,697 |
| 07/08/26 | USD 4.090 | -2.15% | 3,618,170 |
| 06/08/26 | USD 4.180 | +6.36% | 3,212,514 |
| 05/08/26 | USD 3.930 | -5.76% | 3,678,169 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions

















